Page last updated: 2024-08-24

2',3'-dideoxycytidinene and Dermatitis Medicamentosa

2',3'-dideoxycytidinene has been researched along with Dermatitis Medicamentosa in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broder, S; Lawley, TJ; McNeely, MC; Yarchoan, R1

Other Studies

1 other study(ies) available for 2',3'-dideoxycytidinene and Dermatitis Medicamentosa

ArticleYear
Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection.
    Journal of the American Academy of Dermatology, 1989, Volume: 21, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Administration Schedule; Drug Eruptions; Drug Evaluation; HIV Antigens; Humans; Male; Middle Aged; Mouth Diseases; T-Lymphocytes, Helper-Inducer; Ulcer; Zalcitabine

1989